Dr. Ivan Lozada Lawag is a multidisciplinary scientist whose research integrates natural products chemistry, pharmaceutical sciences, analytical chemistry, and pharmacology, with a strong focus on the molecular bioactivity of compounds from medicinal plants and bee products. His work emphasizes antioxidant, antidiabetic, anti-inflammatory, and therapeutic mechanisms, supported by rigorous method development and validation using HPTLC, HPLC, LC–MS/MS, and spectrophotometry.
A 2024 DOST–PCHRD Balik Scientist Awardee, Dr. Lawag is hosted by the Institute of Herbal Medicine, National Institutes of Health, University of the Philippines Manila. He leads projects on bioactivity-guided assays, molecular pharmacology, and therapeutic drug monitoring for anticancer agents, while actively mentoring Filipino researchers in analytical techniques and scientific publishing.
He earned his Ph.D. in Pharmacy from The University of Western Australia, where he established an HPTLC-based phenolic fingerprint database for Western Australian honey, contributing mechanistic insights into the therapeutic value of bee products. He has published in Antioxidants, Molecules, Foods, and PLOS ONE, with over 556 citations (h-index: 11, i10-index: 11). Dr. Lawag is actively involved in journal development and research policy through PAMJE and the CENTRAL project and is a member of MRSC, ACSE, APAME, WAME, and PAMJE.
Dr. Ivan Lozada Lawag is a multidisciplinary scientist whose research integrates natural products chemistry, pharmaceutical sciences, analytical chemistry, and pharmacology, with a strong focus on the molecular bioactivity of compounds from medicinal plants and bee products. His work emphasizes antioxidant, antidiabetic, anti-inflammatory, and therapeutic mechanisms, supported by rigorous method development and validation using HPTLC, HPLC, LC–MS/MS, and spectrophotometry.
A 2024 DOST–PCHRD Balik Scientist Awardee, Dr. Lawag is hosted by the Institute of Herbal Medicine, National Institutes of Health, University of the Philippines Manila. He leads projects on bioactivity-guided assays, molecular pharmacology, and therapeutic drug monitoring for anticancer agents, while actively mentoring Filipino researchers in analytical techniques and scientific publishing.
He earned his Ph.D. in Pharmacy from The University of Western Australia, where he established an HPTLC-based phenolic fingerprint database for Western Australian honey, contributing mechanistic insights into the therapeutic value of bee products. He has published in Antioxidants, Molecules, Foods, and PLOS ONE, with over 556 citations (h-index: 11, i10-index: 11). Dr. Lawag is actively involved in journal development and research policy through PAMJE and the CENTRAL project and is a member of MRSC, ACSE, APAME, WAME, and PAMJE.